Zetola NM, Pilcher CD, et al. Diagnosis and management of
acute HIV infection. Infect Dis Clin North Am. 2007, 21(1): 19-48.
 Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1
infection with early antiretroviral therapy. N Engl J Med. 2011, 365(6): 493-505.
 Ryom L, Mocroft A, Kirk O, et al. Association between
antiretroviral exposure and renal impairment among HIV-positive persons with
normal baseline renal function: the D:A:D Study. J Infec Dis. 2013, 207(9):
 Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of
reports of randomized clinical trials: is blinding necessary?
Control Clin Trials. 1996, 17(2): 1-12.
 Falzon D, Jaramillo E, Schünemann HJ,
et al. WHO guidelines for the programmatic management of drug-resistant
tuberculosis: 2011 update. Eur Respir J. 2011, 38(3): 516-28.
 WHO.Tuberculosisi care with TB-HIV co-management: intergrated
management of adolescent and adult illness(IMAI). 2007.
 Breton G，Chomont N, Takata H, et al. Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection. J Immunol. 2013, 191(5): 2194-204.
 Chen,T, Ding EL, Seage Lii GR, et
al. Meta-analysis: increased mortality associated with hepatitis C in
HIV-infected presons is unrelated to HIV disease progression. Clin Infect Dis. 2009,
 Simon C, et al. Why the “when to
start” question is complex and informed by limited evidence:a response to Dr
May 2013, HTB South. http://i-base.info/htb-south/2341
 Drak JW, et al. Rates of
spontaneous mutation among RNA viruses. Proc Natl Acad Sci USA. 1993, 90(9):
 Bonner K, Mezochow A, Robert T, et
al. Voral load monitoring as a tool to reinforce adherence: a systematic
review. J Acquir Immune Defic Syndr. 2013, 64(1): 74-8.